Science Videos

from AP, Reuters, AFP, and other news services

Catching clots: Saving a-fib patients

Date:
February 3, 2014
Source:
Ivanhoe / Powered by NewsLook.com
Summary:
Hundreds of thousands of people are a little off beat ... that is, their heart is not in perfect rhythm. It could end up causing clots and a stroke. Now, new technology is catching those clots before they can do any damage.


Related Videos

last updated on 2014-09-02 at 6:20 am EDT

Diagnosing Deadly Blood Clots?

Diagnosing Deadly Blood Clots?

Ivanhoe (Sep. 10, 2013) — More people die from preventable blood clots than from breast cancer, AIDS, and traffic accidents combined. Researchers are now taking new measures to evaluate your risk of developing potentially deadly blood clots.
Powered by NewsLook.com
Bursting Blood Clots: Medicine’s Next Big Thing?

Bursting Blood Clots: Medicine’s Next Big Thing?

Ivanhoe (Dec. 16, 2013) — It’s a new drug that could destroy blood clots before there’s permanent damage to the brain. We’ll show you how it could help patients survive without any signs of a stroke.
Powered by NewsLook.com
Parkinson's Drug Linked to Artistic Spark

Parkinson's Drug Linked to Artistic Spark

Reuters (Feb. 11, 2013) — A drug used to ease the symptoms of Parkinson's disease has also been found to boost the creativity of patients who are taking it. Levodopa is designed to increase dopamine levels in the brains of Parkinson's patients suffering from tremors, but researchers in Israel say that in some patients, it's also sparking an outpouring of artistic expression.
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins